No­var­tis sues over IRA ahead of En­tresto price ne­go­ti­a­tions

No­var­tis is the lat­est drug­mak­er to sue the fed­er­al gov­ern­ment over the In­fla­tion Re­duc­tion Act af­ter learn­ing its block­buster heart drug En­tresto will be up …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER